Abstract
Stress hyperglycemia is common in critically ill and injured patients and is a component of the “fight-and-flight” response. Until recently, stress hyperglycemia was considered a beneficial adaptive response, with the raised blood glucose providing a ready source of fuel for the brain, skeletal muscle, heart, and other vital organs at a time of increased metabolic demand. However, retrospective studies in patients undergoing cardiac surgery suggested that perioperative hyperglycemia was associated with an increased risk of postoperative infections and increased mortality.1–3 Furthermore, these studies suggested that control of blood glucose reduced these complications. Following the first Leuven Intensive Insulin Therapy Trial in 2001, “tight glucose control” became regarded as the standard of care in all ICU patients around the world.4
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endoc Pract. 2006;12(Suppl) 3:22–26.
Furnary AP, Wu Y. Eliminating the diabetic disadvantage: the Portland diabetic project. Semin Thorac Cardiovasc Surg. 2006;18:302–308.
Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356–361.
van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–1367.
Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endoc Pract. 2004;10:77–82.
Critchell C, Savarese V, Callahan A, et al. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med. 2007;33:2079–2084.
Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33:2778–2785.
van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–461.
Devos P, Preiser JC, Melot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of glucotrol [European society of Intensive Care Medicine 20th Annual Congress abstract 0735]. Intensive Care Med. 2007;33(suppl 2):S189.
Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–139.
De La Rosa GD, Donado JH, Restrepo AH, et al. Strict glycemic control in patients hospitalized in a mixed medical and surgical intensive care unit: a randomized clinical trial. Crit Care. 2008;12:R120.
Arabi Y, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190–3197.
Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. The NICE-Sugar Study Investigators. N Engl J Med. 2009;360:1283–1297.
Oddo M, Schmidt M, Carrera E, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med. 2008;36:33233–33238.
Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. 2007;120:563–567.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Marik, P.E. (2010). Stress Hyperglycemia and Glycemic Control. In: Handbook of Evidence-Based Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5923-2_39
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5923-2_39
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5922-5
Online ISBN: 978-1-4419-5923-2
eBook Packages: MedicineMedicine (R0)